An allelotype of papillary thyroid cancer
β Scribed by Joseph A. Califano; Michael M. Johns III; William H. Westra; Miriam N. Lango; David Eisele; Motoyasu Saji; Martha A. Zeiger; Robert Udelsman; Wayne M. Koch; David Sidransky
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 336 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Although papillary carcinoma accounts for approximately 70% of all thyroid cancers, preliminary studies of allelic loss have thus far not identified any areas of chomosomal deletion. We evaluated 30 papillary thyroid carcinomas for chromosomal loss/allelic imbalance by testing at least 2 microsatellite markers from every autosomal arm. Fifteen of the 30 tumors tested exhibited loss of heterozygosity/allelic imbalance (LOH/AI) at one or more loci. Chromosomal arms with frequent LOH/AI included 4q, Sp, 7p and I I p. An average of I. I chromosomal arms displayed LOH/AI in each individual tumor. Therefore, 4q, 5p, 7p and, to a lesser extent, I I p display significant LOH/AI in papillary thyroid cancer, which indicates the presence of putative tumor-suppressor gene loci at these chromosomal arms.
π SIMILAR VOLUMES
## Abstract ## Background The most controversial change in the new pathological tumour node metastasis (pTNM) classification of thyroid tumours is the extension of the pT1 classification to include tumours up to 20 mm. ## Methods Four hundred and three patients with pT1 or pT2 differentiated thy
Of 731 patients with papillary thyroid cancer, 91 had metastases outside regional lymph nodes. The most common site was intrathoracic, occurring in 73 of the 91 patients. Miliary, micronodular pulmonary metastases, with iodine 131 (1-131) uptake and "curable'\* by 1-131 treatment were encountered in
We read with great interest the article by Ohori and Schoedel on the cytology of high-grade papillary thyroid carcinoma. 1 Two questions should be addressed. First, a feature illustrated by their Figure 2 is the presence of neutrophils in the epithelium of tall-cell carcinoma. Our group previously